Literature DB >> 1848011

Interaction of the v-rel protein with an NF-kappa B DNA binding site.

N Kabrun1, J W Hodgson, M Doemer, G Mak, B R Franza, P J Enrietto.   

Abstract

The avian reticuloendotheliosis virus T contains within its genome the oncogene rel. The expression of this gene is responsible for the induction of lymphoid tumors in birds. Recently, the rel gene was shown to be related to the p50 DNA binding subunit of the transcription factor complex NF-kappa B. Binding sites for the NF-kappa B complex are found in the enhancer regions of a number of genes, including the immunoglobulin kappa gene and the human immunodeficiency virus long terminal repeat. In this communication we identify an activity from avian reticuloendotheliosis virus T-transformed avian lymphoid cells that binds in an electrophoretic-mobility-shift assay to an NF-kappa B binding site from the kappa enhancer. This activity contains proteins immunologically related to rel, as detected by polyclonal and monoclonal antibodies directed against v-rel. In a DNA affinity precipitation assay using the NF-kappa B site from the human immunodeficiency virus long terminal repeat, v-rel and several other proteins were identified. These data suggest that oncogenic transformation by v-rel is the result of an altered pattern of gene expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848011      PMCID: PMC51109          DOI: 10.1073/pnas.88.5.1783

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

Review 1.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

2.  Characterization of cellular proteins recognizing the HIV enhancer using a microscale DNA-affinity precipitation assay.

Authors:  B R Franza; S F Josephs; M Z Gilman; W Ryan; B Clarkson
Journal:  Nature       Date:  1987 Nov 26-Dec 2       Impact factor: 49.962

3.  The graded distribution of the dorsal morphogen is initiated by selective nuclear transport in Drosophila.

Authors:  C A Rushlow; K Han; J L Manley; M Levine
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

4.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

5.  Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.

Authors:  K Kawakami; C Scheidereit; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.

Authors:  C Gélinas; H M Temin
Journal:  Oncogene       Date:  1988-10       Impact factor: 9.867

7.  Dorsal, an embryonic polarity gene in Drosophila, is homologous to the vertebrate proto-oncogene, c-rel.

Authors:  R Steward
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

8.  p59v-rel, the transforming protein of reticuloendotheliosis virus, is complexed with at least four other proteins in transformed chicken lymphoid cells.

Authors:  S Simek; N R Rice
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

9.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

10.  Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

View more
  15 in total

1.  The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.

Authors:  W H Walker; B Stein; P A Ganchi; J A Hoffman; P A Kaufman; D W Ballard; M Hannink; W C Greene
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein.

Authors:  S Kumar; A B Rabson; C Gélinas
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

3.  AP-1 factors play an important role in transformation induced by the v-rel oncogene.

Authors:  J Kralova; A S Liss; W Bargmann; H R Bose
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

4.  Differential pp40I kappa B-beta inhibition of DNA binding by rel proteins.

Authors:  J A Diehl; T A McKinsey; M Hannink
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

5.  Temperature-sensitive transforming mutants of the v-rel oncogene.

Authors:  D W White; T D Gilmore
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

6.  Constitutive and inducible kappa B binding activities in the cytosol of v-Rel-transformed lymphoid cells.

Authors:  J Hodgson; P J Enrietto
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

7.  Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel.

Authors:  J A Diehl; M Hannink
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 8.  The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma.

Authors:  Im-Soon Lee; Seok Hyung Kim; Hyung Geun Song; Seong Hoe Park
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

9.  A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.

Authors:  V Bours; P R Burd; K Brown; J Villalobos; S Park; R P Ryseck; R Bravo; K Kelly; U Siebenlist
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

10.  p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.

Authors:  A J Capobianco; D Chang; G Mosialos; T D Gilmore
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.